Thibault de La Motte Rouge

Thibault de La Motte Rouge

UNVERIFIED PROFILE

Are you Thibault de La Motte Rouge?   Register this Author

Register author
Thibault de La Motte Rouge

Thibault de La Motte Rouge

Publications by authors named "Thibault de La Motte Rouge"

Are you Thibault de La Motte Rouge?   Register this Author

40Publications

1211Reads

41Profile Views

From Targeting Somatic Mutations to Finding Inherited Cancer Predispositions: The Other Side of the Coin.

Diagnostics (Basel) 2019 Jul 26;9(3). Epub 2019 Jul 26.

Department of pathology, Centre Jean Perrin, 63000 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/diagnostics9030083DOI Listing
July 2019

Therapeutic innovations in breast cancer.

Presse Med 2019 May 29. Epub 2019 May 29.

Centre Eugène-Marquis, avenue Bataille Flandres-Dunkerque, 35000 Rennes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2019.04.005DOI Listing
May 2019

Tumor analysis: freeze-thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cells.

BMC Res Notes 2018 Jun 20;11(1):401. Epub 2018 Jun 20.

COSS (Chemistry Oncogenesis Stress Signaling)-UMR 1242, Inserm, Univ Rennes, CLCC Eugène Marquis, Rue Bataille Flandres Dunkerque, 35042, Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13104-018-3504-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011598PMC
June 2018

Fluctuating Behavior of the French Population in Cancer Screening: 5th Edition of the EDIFICE Survey.

Curr Oncol Rep 2018 03 5;20(Suppl 1):14. Epub 2018 Mar 5.

INSERM, IRD, SESSTIM, Aix Marseille University, 23 rue Stanislas Torrents, 13006, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0646-xDOI Listing
March 2018

Cancer de l’ovaire : la rechute précoce.

Bull Cancer 2017 May;104 Suppl 1:S32-S38

Département de cancérologie gynécologique, centre Oscar-Lambret, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(17)30160-1DOI Listing
May 2017

Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.

Gynecol Oncol 2016 09 8;142(3):452-7. Epub 2016 Jul 8.

Department of Cancer Medicine, Institut Gustave-Roussy, 114 rue Edouard Vaillant, F-94805 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.07.005DOI Listing
September 2016

Dynamic Analysis of CA125 Decline During Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer as a Predictor for Platinum Sensitivity.

Anticancer Res 2016 Apr;36(4):1865-71

Department of Breast and Gynecological Surgery, Institut Curie, Paris, France Versailles-St-Quentin-en-Yvelines University, EA 7285: Risques Cliniques et Sécurité en Santé des Femmes et en Santé Périnatale, Montigny-Le-Bretonneux, France.

View Article

Download full-text PDF

Source
April 2016

[Fertility sparing treatment in women affected by cervical cancer larger than 2cm].

Bull Cancer 2016 Feb 8;103(2):173-9. Epub 2015 Dec 8.

Hôpital, institut Curie, département de chirurgie, 5248 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.11.005DOI Listing
February 2016

Anticancer treatment and fertility: Effect of therapeutic modalities on reproductive system and functions.

Crit Rev Oncol Hematol 2016 Jan 8;97:328-34. Epub 2015 Aug 8.

Oncology Department, Attikon Hospital, University of Athens, 1 Rimini, 12462, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.08.002DOI Listing
January 2016

Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies.

Eur Urol 2015 Aug 2;68(2):228-35. Epub 2014 May 2.

Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.04.015DOI Listing
August 2015

[Communication in the context of phase I clinical trials in oncology: implementation and evaluation of training programs].

Bull Cancer 2015 Feb 15;102(2):174-81. Epub 2015 Jan 15.

Institut Gustave-Roussy, département interdisciplinaire de soins de support aux patients en oncohématologie, 114, rue Édouard-Vaillant, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2014.12.013DOI Listing
February 2015

CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy.

Gynecol Oncol 2014 Dec 16;135(3):542-6. Epub 2014 Sep 16.

Department of breast and gynecological surgery, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex, France; Versailles-St-Quentin-en-Yvelines University, EA 7285: Risques cliniques et sécurité en santé des femmes et en santé périnatale, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.09.005DOI Listing
December 2014

Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S48-54

*University of Texas MD Anderson Cancer Center, Houston, TX (Gynecologic Oncology Group [GOG]); †Prince of Wales Hospital, Sydney, Australia (Australia and New Zealand Gynecological Oncology Group [ANZGOG]); ‡The Ohio State University, Columbus, OH (GOG); §Kliniken Essen-Mitte, Essen, Germany (AGO); ∥University of Louisville, Louisville, KY (GOG); ¶Institut Curie, Hôpital Rene Huguenin, Saint Cloud, France (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens [GINECO]); #Fondazione IRCCS National Cancer Institute of Milan, Italy (Multicentre Italian Trials in Ovarian Cancer); **Tampere University Hospital, Tampere, Finland (Nordic Society of Gynaecological Oncology); ††Seoul National University College of Medicine, Seoul, Korea (Korean Gynecologic Oncology Group); ‡‡The University of Chicago, Chicago, IL (GOG); and §§Charing Cross Hospital, London, UK (Medical Research Council/National Cancer Research Institute [MRC NCRI]).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000223DOI Listing
November 2014

[Targeted therapy in locally and metastatic recurrent cervical cancers].

Bull Cancer 2014 Jul-Aug;101(7-8):748-55

Institut Curie, site Paris, Département d'oncologie médicale, 26, rue d'Ulm, 75248 Paris cedex 05, France, Université Paris Descartes, 12, rue de l'École-de-Médecine, 75270 Paris cedex 06, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2014.1949DOI Listing
September 2014

[Management of enzalutamide, a new hormonal therapy].

Bull Cancer 2014 Jan;101(1):107-12

Institut Curie, Hôpital René-Huguenin, 35, rue Dailly, 92100 Saint-Cloud, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2013.1880DOI Listing
January 2014

Five-year survival in patients with cytokine-refractory metastatic renal cell carcinoma treated with axitinib.

Clin Genitourin Cancer 2013 Jun 4;11(2):107-14. Epub 2013 Feb 4.

Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2012.12.004DOI Listing
June 2013

Current role of diethylstilbestrol in the management of advanced prostate cancer.

BJU Int 2012 Dec 11;110(11 Pt C):E826-9. Epub 2012 May 11.

Urology Academic Department of la Pitié-Salpêtrière Hospital, Assistance Publique- Hôpitaux de Paris, Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11206.xDOI Listing
December 2012

[Non oncologic applications of molecular targeted therapies].

Bull Cancer 2012 Oct;99(10):953-62

Groupe hospitalier Pitié-Salpêtrière - Charles-Foix, service d'oncologie médicale, Paris Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2012.1641DOI Listing
October 2012

Renal cell carcinoma: focus on safety and efficacy of temsirolimus.

Clin Med Insights Oncol 2010 Dec 19;4:143-54. Epub 2010 Dec 19.

Service de Radiothérapie, Groupe Hospitalier Pitié Salpétrière, 47-83, boulevard de l'Hôpital, 75651 Paris Cedex 13, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMO.S4482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018897PMC
December 2010

[Clinical and molecular predictors of response to EGFR tyrosine kinase inhibitors in non-small cell lung cancer].

Ann Pathol 2007 Oct;27(5):353-63

Institut Gustave Roussy, Département de biologie et pathologie médicales, 94805 Villejuif.

View Article

Download full-text PDF

Source
October 2007

Methods for the assessment of mitochondrial membrane permeabilization in apoptosis.

Apoptosis 2007 May;12(5):803-13

INSERM U848, Institut Gustave Roussy PR 1, 30 rue Camille Desmoulins, F-94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10495-007-0720-1DOI Listing
May 2007

[Medical treatment of metastatic or recurrent cancer of the cervix].

Bull Cancer 2006 Mar;93(3):263-70

Comité de gynécologie médicale, Institut Gustave Roussy, 39 rue Camille-Desmoulins, 94805 Villejuif Cedex.

View Article

Download full-text PDF

Source
March 2006

[Cannabis and cancer].

Bull Cancer 2006 Feb;93(2):163-70

Association d'études et de recherche des Internes en oncologie, 24, rue Victor Massé, 75009 Paris.

View Article

Download full-text PDF

Source
February 2006

[Anemia in lymphoma].

Bull Cancer 2005 May;92(5):429-31

Département de Gynécologie, Institut Gustave-Roussy, 39 rue Camille-Desmoulins, 94 800 Villejuif.

View Article

Download full-text PDF

Source
May 2005